Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories, today ...
An analyst from Goldman Sachs has decided to maintain their Buy rating on Guardant Health, which currently sits at a price ...
Q1 2024 Earnings Call Transcript May 12, 2024 SOPHiA GENETICS SA isn’t one of the 30 most popular stocks among hedge funds at ...
Cancer biopsy tests sold to biopharma companies for use in clinical studies, meanwhile, grew 37% to 8,450. “We also saw continued progress in our EMR integration efforts which streamlines orders and ...
Ultrasound imaging offers a valuable and noninvasive way to find and monitor cancerous tumors. However, much of the most ...
Healthcare Asia on MSN2d
Enteral feeding devices market size to grow by 6.42% CAGR until 2027The market is expected to grow by $1.36b within the forecast period. The global enteral feeding devices market size is ...
Having examined the options trading patterns of Guardant Health, our attention now turns directly to the company. This shift ...
Medicare is currently barred from covering drugs for weight losses purposes. But roughly 61% of adults say they think ...
The innovative AIM-listed company, which is focused on delivering lighting, science and plant monitoring solutions for use in ...
Analyst Puneet Souda of Leerink Partners maintained a Buy rating on Exact Sciences (EXAS – Research Report), reducing the price target to ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended March 31, 2024. First Quarter 2024 Financial Highl ...
Pancreatic cancer comes in many forms, and though inherently aggressive, researchers are hopeful. Here’s everything you need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results